Valuation : Kenvue Inc.

Market Cap 36.82B 31.69B 29.74B 27.17B 51B 3,504B 51.39B 353B 137B 1,773B 138B 135B 5,882B P/E 2026 *
19.9x
P/E 2027 * 17.2x
Enterprise Value 43.92B 37.8B 35.48B 32.41B 60.84B 4,179B 61.3B 420B 164B 2,115B 165B 161B 7,015B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.71x
Free-Float
98.88%
Yield 2026 *
4.47%
Yield 2027 * 4.56%
1 day-1.51%
1 week-0.94%
Current month-1.87%
1 month-2.23%
3 months+9.26%
6 months-0.05%
Current year+9.45%
1 week 18.82
Extreme 18.825
19.47
1 month 18.65
Extreme 18.65
19.7
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.82
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%-0.94%-8.84%-18.16% 36.82B
+0.93%+0.30%-7.59%-5.79% 334B
+0.51%+2.03%-8.74%+4.42% 139B
-1.02%-1.38%+6.84%+21.62% 72.34B
-2.14%-2.36%-26.03%-22.30% 49.42B
-0.72%+0.35%+11.52%-37.46% 37.41B
+0.17%+2.39%+8.62%+29.62% 20.56B
-1.62%-2.66%-19.05%-34.50% 20.35B
+0.18%-0.18%+10.12%+9.78% 19.81B
-1.50%-3.40%-27.47%-11.68% 9.8B
Average -0.67%+0.66%-6.06%-6.45% 73.99B
Weighted average by Cap. +0.11%+0.28%-6.38%-3.97%

Financials

2026 *2027 *
Net sales 15.6B 13.42B 12.6B 11.51B 21.6B 1,484B 21.77B 149B 58.11B 751B 58.55B 57.28B 2,491B 15.97B 13.74B 12.9B 11.78B 22.12B 1,519B 22.29B 153B 59.49B 769B 59.95B 58.64B 2,551B
Net income 1.83B 1.58B 1.48B 1.35B 2.53B 174B 2.55B 17.52B 6.82B 88.13B 6.87B 6.72B 292B 2.11B 1.82B 1.71B 1.56B 2.93B 201B 2.95B 20.23B 7.87B 102B 7.93B 7.76B 337B
Net Debt 7.1B 6.11B 5.73B 5.24B 9.83B 675B 9.91B 67.95B 26.44B 342B 26.65B 26.07B 1,134B 6.52B 5.61B 5.27B 4.81B 9.03B 620B 9.1B 62.42B 24.29B 314B 24.48B 23.95B 1,041B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-31 US$18.88 -1.51% 26,363,433
26-08-28 US$19.17 -0.16% 11,888,632
26-08-27 US$19.20 -0.10% 14,741,652
26-08-26 US$19.22 -0.57% 25,400,462
26-08-25 US$19.33 -0.51% 20,421,152
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.17USD
Average target price
19.50USD
Spread / Average Target
+1.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock